Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal registred%No. of excluded casesIncluded cases
HVDCODCONo. follow-upOthersTotal%No.%
China - Hong Kong SAR 1996-200130990.00.62019216.828893.2
China - Qidong 1992-20004577.80.000000.045100.0
China - Shangai 1992-199520079.50.000000.0200100.0
China - Tianjin 1991-199917077.60.000331.816798.2
Singapore 1993-19977398.60.001122.77197.3
Republic of Korea - Busan 1996-200110889.83.741054.610395.4
Republic of Korea - Incheon 1997-20015286.53.820023.85096.2
Republic of Korea - Seoul 1993-199724685.44.511110228.922491.1
Thailand - Chiang Mai 1993-19973976.90.0060615.43384.6
Thailand - Lampang 1990-20004285.70.000000.042100.0
Thailand - Songkhla 1990-19994795.70.0050510.64289.4



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period